V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300006108 | 300004195 | 1.49 | 48.1 | Palliative (P) | 2016-12-12 | 2017-03-21 | NIVOLUMAB | N | N | 300014366 | CAPECITABINE + GEMCITABINE |
| 300006109 | 300004196 | 1.71 | 65.6 | Palliative (P) | 2017-09-25 | 2017-12-27 | Capecitabine | N | Y | 300014390 | CISPLATIN |
| 300006110 | 300004197 | 1.65 | null | Curative (C) | 2016-09-03 | 2016-09-17 | Cisplatin | 02 | Y | 300014390 | CETUXIMAB |
| 300006111 | 300004198 | null | 63.2 | Palliative (P) | null | 2017-08-05 | Cisplatin | N | N | 300014406 | CAPECITABINE + OXALIPLATIN |
| 300006112 | 300006743 | 1.55 | 76.2 | Palliative (P) | 2015-05-07 | 2015-05-15 | CARBOPLATIN + Cetuximab + FLUOROURACIL | N | N | 300014415 | CAPECITABINE |
| 300006113 | 300004200 | 1.6 | 82.1 | Not known (9) | 2017-07-17 | 2017-07-20 | Cetuximab 7 day (Cycle 1) | 02 | N | 300014416 | TRIAL |
| 300006114 | 300006744 | 1.65 | null | Palliative (P) | 2016-12-19 | 2016-12-19 | Capecitabine + Oxaliplatin 21day | N | N | 300014421 | PACLITAXEL |
| 300006119 | 300008324 | 1.7 | 65.4 | Palliative (P) | 2015-01-13 | 2015-01-20 | Capecitabine (21days) + Carboplatin | N | N | 300014501 | CAPECITABINE |
| 300006120 | 300004204 | 1.7 | 70.4 | Palliative (P) | 2013-06-29 | 2013-06-30 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 300014524 | CISPLATIN + FLUOROURACIL |
| 300006121 | 300004205 | 1.8 | 86.4 | Palliative (P) | null | 2016-03-16 | Cetuximab 7 day (Cycle 1) | N | N | 300014524 | CARBOPLATIN |
| 300006122 | 300004207 | 1.69 | 34 | Palliative (P) | 2015-01-23 | 2015-01-23 | Oxaliplatin + Modified de Gramont | N | N | 300014526 | CARBOPLATIN + ETOPOSIDE |
| 300006123 | 300004209 | null | null | null | null | 2016-11-17 | Gemcitabine + Oxaliplatin | N | N | 300014577 | CAPECITABINE + GEMCITABINE |
| 300006124 | 300004210 | 1.59 | 34 | Palliative (P) | 2015-02-06 | 2015-03-01 | Capecitabine (21days) + Carboplatin | N | null | 300014602 | CAPECITABINE |
| 300006125 | 300006751 | null | null | Palliative (P) | 2013-10-20 | 2013-10-30 | Capecitabine + Oxaliplatin 21day | Y | N | 300014610 | OXALIPLATIN + MDG |
| 300006126 | 300004211 | 1.73 | 60.6 | Palliative (P) | 2015-05-08 | 2015-05-08 | Capecitabine + Oxaliplatin 21day | 02 | N | 300014612 | CAPECITABINE + OXALIPLATIN |
| 300006127 | 300006752 | 1.55 | null | Neo-adjuvant (N) | null | 2014-11-13 | Cisplatin 7 day | N | Y | 300014614 | CARBOPLATIN |
| 300006128 | 300004212 | null | 58.9 | Palliative (P) | 2017-04-19 | 2017-04-26 | DE-ESCALATE TRIAL | N | null | 300014618 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 300006129 | 300004214 | 1.82 | 62.8 | Palliative (P) | 2016-03-28 | 2016-04-22 | Cetuximab +Cisplatin + FU (Cycle 1) | 02 | N | 300014629 | TRIAL |
| 300006130 | 300006754 | 1.71 | 0 | Palliative (P) | 2017-11-17 | 2017-11-27 | Cisplatin | 02 | N | 300014632 | BEVACIZUMAB |
| 300006131 | 300004215 | 1.82 | 129.9 | Palliative (P) | 2014-06-05 | 2014-06-26 | Cisplatin | N | N | 300014663 | IRINOTECAN + MDG |
| 300006132 | 300004215 | 1.67 | 91.4 | Not known (9) | 2013-12-11 | 2014-08-12 | CHOP - 21 days | N | N | 300014663 | CARBOPLATIN + ETOPOSIDE |
| 300006133 | 300004216 | 1.6 | 91.8 | Palliative (P) | 2014-06-23 | 2014-07-06 | LUX TRIAL | N | null | 300014664 | OXALIPLATIN + MDG |
| 300006134 | 300004217 | 1.7 | 95 | Palliative (P) | 2014-12-03 | 2014-12-06 | Carboplatin AUC 2 - 5 | N | N | 300014670 | CETUXIMAB + RT |
| 300006135 | 300004218 | 1.63 | 62 | Palliative (P) | null | 2017-01-26 | Cisplatin | N | N | 300014670 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300006136 | 300004218 | 0 | 63 | null | 2017-04-02 | 2017-04-02 | Capecitabine + Mitomycin | N | N | 300014670 | CETUXIMAB |
| 300006137 | 300004220 | null | 60 | Palliative (P) | 2014-10-06 | 2014-12-25 | Gemcitabine + Capecitabine | N | N | 300014692 | TRIAL |
| 300006138 | 300004221 | 1.84 | 103.2 | Palliative (P) | 2016-11-14 | 2016-11-25 | Cisplatin +Fluorouracil (3 wk) | Y | N | 300014706 | CISPLATIN + FLUOROURACIL |
| 300006139 | 300004222 | 1.64 | 82 | Palliative (P) | 2015-12-05 | 2015-12-16 | Cisplatin | N | N | 300014712 | IRINOTECAN + MDG |
| 300006140 | 300004223 | null | 75 | Palliative (P) | 2014-11-11 | 2014-11-12 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300014734 | TRIAL |
| 300006141 | 300004223 | 1.56 | null | Palliative (P) | 2013-11-10 | 2013-11-11 | TRASTUZUMAB | 02 | N | 300014734 | NOT MATCHED |
| 300006145 | 300004227 | null | 88.3 | Palliative (P) | 2015-07-05 | 2015-07-17 | Cetuximab 7 day (>Cycle 2) | 02 | N | 300014806 | OXALIPLATIN + MDG |
| 300006146 | 300004227 | 1.64 | 70.3 | Palliative (P) | 2014-07-06 | 2014-07-08 | Bevacizumab 10mg/kg | 02 | N | 300014806 | CYTARABINE |
| 300006147 | 300004228 | 1.6 | 40 | Palliative (P) | 2015-06-02 | 2015-06-12 | Gemcitabine + Capecitabine | N | N | 300014818 | CAPECITABINE |
| 300006148 | 300007715 | 1.68 | 67.7 | Palliative (P) | 2014-10-21 | 2014-11-25 | CNS LGG | Y | N | 300014838 | TRIAL |
| 300006149 | 300004229 | 1.66 | 73.8 | Neo-adjuvant (N) | 2015-03-13 | 2015-03-26 | Carboplatin AUC 2 - 5 | 02 | Y | 300014844 | CARBOPLATIN |
| 300006152 | 300004232 | 1.69 | 42.3 | Palliative (P) | 2016-02-27 | 2016-03-30 | CNS LGG Irinotecan & Bevacizumab | N | N | 300014856 | NOT MATCHED |
| 300006153 | 300004232 | 1.68 | 86.4 | Palliative (P) | 2017-07-24 | 2017-07-27 | Carboplatin AUC 2 - 5 | 02 | N | 300014856 | ESPAC TRIAL |
| 300006154 | 300004234 | 1.61 | 62 | Palliative (P) | null | 2015-11-14 | VAC | 02 | N | 300014859 | CAPECITABINE |
| 300006155 | 300004235 | 1.55 | null | Palliative (P) | 2014-05-21 | 2014-05-21 | Carboplatin + Paclitaxel (3 weekly) | 02 | null | 300014880 | CISPLATIN + FLUOROURACIL |
| 300006156 | 300004235 | 1.71 | null | Palliative (P) | 2016-06-23 | 2016-07-01 | Trial Unspecified | N | N | 300014880 | CAPECITABINE + GEMCITABINE |
| 300006158 | 300004238 | 1.81 | 97.7 | Palliative (P) | 2014-04-20 | 2014-04-20 | Trial Unspecified | N | N | 300014892 | NIVOLUMAB |
| 300006159 | 300004241 | 1.67 | null | Palliative (P) | 2014-05-14 | 2014-06-12 | Capecitabine | N | N | 300014897 | ESPAC TRIAL |
| 300006160 | 300004241 | 1.65 | 85.9 | Palliative (P) | 2014-04-05 | 2014-04-24 | Carboplatin AUC 6 - 10 | 02 | N | 300014897 | CISPLATIN + FLUOROURACIL |
| 300006161 | 300004242 | null | 66.35 | Palliative (P) | 2013-12-23 | 2013-12-24 | CAPECITABINE + OXALIPLATIN | N | N | 300014927 | TRIAL |
| 300006162 | 300004246 | 1.81 | 69.4 | Palliative (P) | 2014-12-24 | 2014-12-30 | Cisplatin | N | Y | 300014930 | CARBOPLATIN + RT |
| 300006163 | 300004247 | 1.75 | 83.2 | Palliative (P) | 2015-08-08 | 2015-09-11 | Bevacizumab 7.5mg/kg | N | N | 300014937 | CISPLATIN |
| 300006164 | 300004248 | 1.67 | 58.8 | Palliative (P) | 2014-05-28 | 2014-06-19 | Cetuximab+Cisplatin+FU (> Cycle 2) | N | N | 300014941 | GEMCARBO |
| 300006165 | 300004249 | 1.78 | 86.1 | Palliative (P) | 2014-06-13 | 2015-11-08 | Capecitabine (14 days)+Carboplatin | 2 | N | 300014945 | TEMOZOLOMIDE |
| 300006166 | 300004250 | 1.6 | 75 | Palliative (P) | 2016-05-09 | 2016-05-26 | CAPECITABINE + OXALIPLATIN | 02 | N | 300014948 | OXALIPLATIN + MDG |
| 300006167 | 300004252 | null | 70.6 | Palliative (P) | null | 2015-05-11 | CISPLATIN + FLUOROURACIL | Y | N | 300014956 | LENALIDOMIDE |